ALARIS GP LVP DRUGS & DOSING
Report
- Report Number
- 9616066-2020-20124
- Event Type
- Injury
- Date Received
- October 20, 2020
- Date of Event
- September 24, 2020
- Report Date
- October 12, 2020
- Manufacturer
- SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
- Product Code
- FPA
- PMA / PMN Number
- NA
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. MEDICAL DEVICE EXPIRATION DATE: UNKNOWN. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED. DEVICE MANUFACTURE DATE: UNKNOWN. (B)(4).
IT WAS REPORTED THAT ALARIS GP LVP DRUGS & DOSING HAD AIR BUBBLES AND THE PATIENT HAD A STROKE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WE CURRENTLY HAVE THREE PATIENTS WHO HAVE SUFFERED A STROKE AFTER AN ELECTROPHYSIOLOGICAL EXAMINATION. WE HAVE NOTICED THAT AIR BUBBLES ARE FORMING IN THE INFUSOMAT SET. DESPITE PROPER VENTILATION. WITH THIS SYSTEM, A 500 ML NACL 0.9% INFUSION IS FLUSHED WITH 1000 IU HEPARIN. DURING AN ELECTROPHYSIOLOGICAL EXAMINATION, THE INFUSOMAT SET WAS CHECKED EVERY 10 MINUTES. AFTER A SHORT TIME, AIR BUBBLES FORM IN THE SYSTEM THAT ARE NOT DETECTED BY THE INFUSOMAT SENSOR. THE AIR ALARM LIMIT ON THESE DEVICES IS SET TO 500L. >> THE STATION HAS NOW RECEIVED RENTAL DEVICES IN WHICH THE DATA SET WAS SET TO 50<<. REPORTER: I HAVE JUST PHONED THE USER. THEY DO NOT USE A FILTER DURING THE INFUSION. AND THE FLOW RATE IN THE INCIDENTS WAS 60 ML / H AND 180 ML / H. IN TERMS OF URGENCY, I WILL NOW GIVE THE CUSTOMER THE RECOMMENDATION ACCORDING TO OUR GP OPERATING INSTRUCTIONS THAT A FILTER SHOULD BE USED. (60033E) 13TH/10: PATIENTS IN THE EPU (HEART CAT LABORATORY) WE HAD THREE PATIENTS IN THE LAST WEEKS WHO DEVELOPED A MULTISYMBOLIC STROKE AFTER AN ELECTROPHYSIOLOGICAL EXAMINATION. FORTUNATELY, IN ALL CASES, THE CLINICAL SYMPTOMS RECEDED AFTER A FEW DAYS, BUT THE STROKE IS DETECTABLE ON MRI. PATIENT 1 WAS EXAMINED IN HKL 1 (EPU2) DUE TO ATYPICAL ATRIAL FLUTTER WITH THE RHYTHMIA SYSTEM USING THE ORION CATHETER. AT THE END OF THE EXAMINATION, A SLIGHT MOTOR APHASIA AND A CENTRAL FACIAL PARESIS ON THE RIGHT SIDE WERE NOTICEABLE. PATIENT 2 WAS EXAMINED IN HKL 3 (EPU1) DUE TO ATRIAL FIBRILLATION WITH THE CARTO SYSTEM USING THE PANTARAY CATHETER. SHE DEVELOPED ATAXIC HEMISY SYMPTOMS OF THE LEFT ARM ON THE EVENING OF THE EXAMINATION. PATIENT 3 WAS EXAMINED IN HKL 1 (EPU2) DUE TO ATRIAL FIBRILLATION WITH THE POLARX CRYO BALLOON. AT THE END OF THE EXAMINATION HE HAD LEFT ARM AND LEG HEMIPLEGIA. ALL PATIENTS HAD IN COMMON THAT THEY NEEDED A LONG SHEATH IN THE LEFT ATRIUM (DIFFERENT SHEATHS) THROUGH WHICH THE ORION/PENTARAY/POLARX BALLOON WAS INSERTED. TO PREVENT BLOOD CLOTS FROM FORMING, THE AIRLOCKS ARE CONTINUOUSLY FLUSHED WITH NACL+HEPARIN. THE RINSING WAS PERFORMED VIA THE CAREFUSION ALARIS GP PLUS SYSTEM (HVAC 3: MT 06228E; HVAC 1: MT02996E + INFUSION SET: GP VOLUMENTRIC PUMP / SAFETY CLAMP REF: 60593, LOT 1015131). DUE TO THESE INCIDENTS, WE CHECKED THE ALARIS GP PLUS SYSTEM + INFUSION SET IN ANOTHER PATIENT AND OPENED THE SYSTEM EVERY 10MIN TO CHECK FOR AIR BUBBLES. THIS SHOWED THAT A SPONTANEOUS FORMATION OF AIR BUBBLES BELOW THE AIR BUBBLE SENSOR OCCURS. THE AIR BUBBLES WERE REMOVED AND 10 MINUTES LATER THEY WERE DETECTED AGAIN. IN THE CASE OF UNDETECTED AIR BUBBLES, IT IS CONCEIVABLE THAT THESE COULD CAUSE MICROEMBOLISM IN THE PATIENT'S BRAIN, WHICH WOULD BE COMPATIBLE WITH THE CLINICAL SYMPTOMS. OF COURSE, THERE MAY BE OTHER REASONS FOR A STROKE DURING SUCH A PROCEDURE, BUT AIR BUBBLES IN THE LEFT HEART ARE SPECIAL RISK. AFTER REPORTING THE INCIDENTS TO THE MEDICAL TECHNOLOGY DEPARTMENT, NEW EQUIPMENT ON LOAN FROM THE COMPANY WAS IMMEDIATELY PROVIDED. DSS HK-LABORATORY HAS TESTED THE DEVICE ALARIS GP PLUS GUARDRAILS (MT 02996E) WITHOUT PATIENT IN THE ABOVE MENTIONED WAY AND FOUND THE SAME PROBLEM. THE INFUSION SET WAS THE SAME AS ABOVE WHEN TESTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1167548 | ALARIS GP LVP DRUGS & DOSING | INTRAVASCULAR ADMINISTRATION SET | FPA | SISTEMAS MEDICOS ALARIS, S.A. DE C.V. | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |